Within-subject biological variation of activated partial thromboplastin time, prothrombin time, fibrinogen, factor VIII and von Willebrand factor in pregnant women

被引:15
作者
Kristoffersen, Ann Helen [1 ,2 ]
Petersen, Per Hyltoft [2 ]
Bjorge, Line [3 ,4 ]
Roraas, Thomas [2 ]
Sandberg, Sverre [2 ,5 ,6 ]
机构
[1] Haukeland Hosp, Helse Bergen HF, Lab Clin Biochem, PB 1400, N-5021 Bergen, Norway
[2] Haraldsplass Deaconess Hosp, Norwegian Qual Improvement Lab Examinat Noklus, Bergen, Norway
[3] Univ Bergen, Ctr Canc Biomarkers CCBIO, Dept Clin Sci, Bergen, Norway
[4] Haukeland Hosp, Dept Gynecol & Obstet, Bergen, Norway
[5] Haukeland Hosp, Lab Clin Biochem, Bergen, Norway
[6] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway
关键词
biological variation; blood coagulation tests; haemostasis; multiples of median; pregnancy; DISSEMINATED INTRAVASCULAR COAGULATION; REFERENCE CHANGE VALUES; MENSTRUAL BLOOD-LOSS; POSTPARTUM HEMORRHAGE; HEMOSTATIC CHANGES; REFERENCE INTERVALS; CLINICAL-CHEMISTRY; CRITICAL-APPRAISAL; PROTEIN-S; D-DIMER;
D O I
10.1515/cclm-2017-1220
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: During pregnancy, interpretation of results from coagulation parameters can be difficult as the physiological changes that occur may affect the biochemical parameters. The aim of this study was to describe the normal course of five coagulation parameters in healthy pregnancies, and to estimate the within-subject biological variation (CVI). Methods: Blood samples were obtained every 4th week during pregnancy and three samples after delivery in 20 healthy women and every 4th week during a 40-week period in 19 healthy non-pregnant women. Activated partial thromboplastin time (APTT), prothrombin time (PT), PT International Normalized Ratio (INR), fibrinogen, factor VIII clot (FVIII: C) and von Willebrand factor antigen (vWF: Ag) were analyzed. The physiological changes during pregnancy were compensated by transformation into multiples of the median (MoM) and it is natural logarithm (lnMoM) in order to establish a kind of steady state, and CVI was calculated from the standard deviation. Results: During pregnancy, APTT, PT and INR remained unchanged or decreased, depending upon the reagent used, while fibrinogen, FVIII: C and vWF: Ag increased gradually until delivery. The CVI in pregnancy were 2.2 and 3.0% for APTT, 2.3 and 2.6% for PT, 2.2 and 2.3% for INR, 7.2% for fibrinogen, 12.2% for FVIII: C and 11.3% for vWF: Ag, and corresponded with the CVI in non-pregnant women. Conclusions: Transformation of coagulation parameters in healthy pregnancies to MoM is a tool to establish a kind of steady state. Although there is a physiological change in these coagulation parameters during pregnancy, the CVI after lnMoM transformation was comparable with the CVI of non-pregnant women.
引用
收藏
页码:1297 / 1308
页数:12
相关论文
共 49 条
[31]   The effect of levonorgestrel-releasing intrauterine system use on menstrual blood loss and the hemostatic, fibrinolytic/inhibitor systems in women with menorrhagia [J].
Koh, S. C. L. ;
Singh, K. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (01) :133-138
[32]   Levonorgestrel-intrauterine system effects on hemostasis and menstrual blood loss in women seeking contraception [J].
Koh, Stephen C. L. ;
Singh, Kuldip .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2010, 36 (04) :838-844
[33]   Estimates of Within-Subject Biological Variation of Protein C, Antithrombin, Protein S Free, Protein S Activity, and Activated Protein C Resistance in Pregnant Women [J].
Kristoffersen, Ann H. ;
Petersen, Per H. ;
Roraas, Thomas ;
Sandberg, Sverre .
CLINICAL CHEMISTRY, 2017, 63 (04) :898-907
[34]   A model for calculating the within-subject biological variation and likelihood ratios for analytes with a time-dependent change in concentrations; exemplified with the use of D-dimer in suspected venous thromboembolism in healthy pregnant women [J].
Kristoffersen, Ann-Helen ;
Petersen, Per H. ;
Sandberg, Sverre .
ANNALS OF CLINICAL BIOCHEMISTRY, 2012, 49 :561-569
[35]   Could light meal jeopardize laboratory coagulation tests? [J].
Lima-Oliveira, Gabriel ;
Salvagno, Gian Luca ;
Lippi, Giuseppe ;
Danese, Elisa ;
Gelati, Matteo ;
Montagnana, Martina ;
Picheth, Geraldo ;
Guidi, Gian Cesare .
BIOCHEMIA MEDICA, 2014, 24 (03) :343-349
[36]   'Likelihood-ratio' and 'odds' applied to monitoring of patients as a supplement to 'reference change value' (RCV) [J].
Petersen, Per Hyltoft ;
Sandberg, Sverre ;
Iglesias, Natalia ;
Soeletormos, Gyoergy ;
Aarsand, Aasne Karine ;
Brandslund, Ivan ;
Jorgensen, Lone G. M. .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2008, 46 (02) :157-164
[37]   Graphical interpretation of confidence curves in rankit plots [J].
Petersen, PH ;
Blaabjerg, O ;
Andersen, M ;
Jorgensen, LGM ;
Schousboe, K ;
Jensen, E .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (07) :715-724
[38]   Biological Variation: The Effect of Different Distributions on Estimated Within-Person Variation and Reference Change Values [J].
Roraas, Thomas ;
Stove, Bard ;
Petersen, Per Hyltoft ;
Sandberg, Sverre .
CLINICAL CHEMISTRY, 2016, 62 (05) :725-736
[39]   Confidence Intervals and Power Calculations for Within-Person Biological Variation: Effect of Analytical Imprecision, Number of Replicates, Number of Samples, and Number of Individuals [J].
Roraas, Thomas ;
Petersen, Per H. ;
Sandberg, Sverre .
CLINICAL CHEMISTRY, 2012, 58 (09) :1306-1313
[40]   Biological variation in inflammatory and hemostatic markers [J].
Rudez, G. ;
Meijer, P. ;
Spronk, H. M. H. ;
Leebeek, F. W. G. ;
ten Cate, H. ;
Kluft, C. ;
de Maat, M. P. M. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (08) :1247-1255